TMEM189-UBE2V1 抗体 (AA 94-164)
Quick Overview for TMEM189-UBE2V1 抗体 (AA 94-164) (ABIN567051)
抗原
适用
宿主
克隆类型
应用范围
- 
    - 
                                            抗原表位
- AA 94-164
- 
                                            原理
- Mouse polyclonal antibody raised against a partial recombinant Kua-UEV.
- 
                                            序列
- VHWGADTWGS VELPIVGKAF IRPFREHHID PTAITRHDFI ETNGDNCLVT LLPLLNMAYK FRTHSPEALE Q
- 
                                            交叉反应
- 人
- 
                                            产品特性
- Antibody Reactive Against Recombinant Protein.
- 
                                            免疫原
- Kua-UEV (NP_954673, 94 a.a. ~ 164 a.a) partial recombinant protein with GST tag.
 
- 
                                            
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 50 % glycerol
- 
                                            注意事项
- Aliquot to avoid repeated freezing and thawing.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
 
- 
                                            
- 
    - TMEM189-UBE2V1 (TMEM189-UBE2V1 Readthrough (TMEM189-UBE2V1))
- 
                                            别名
- TMEM189-UBE2V1
- 
                                            背景
- 
                        Full Gene Name: TMEM189-UBE2V1 readthrough transcript
 Synonyms: CROC-1B,Kua-UEV,UBE2V1
- 
                                            基因ID
- 387522
- 
                                            NCBI登录号
- NM_199203
 抗原
- 
                    
 
                                     
                                     
                                    